Maryann Feldman and Scott Stern, co-chairs

Jennifer Shieh, SBA

John Williams, SBA

What are the U.S. government’s goals and expectations for the study?

What data can the government make available for committee use?

Jodi Black, National Institutes of Health

Matthew McMahon, National Institutes of Health

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Moderator: Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

John Van Reenen, Massachusetts Institute of Technology

Josh Lerner, Harvard Business School

Moderator: Stephanie Shipp, Biocomplexity Institute and Initiative at the University of Virginia (committee member)

Greg Keenan, Wisconsin Alumni Research Foundation (WARF)

Trevor Loy, Flywheel Ventures

Phil Weilerstein, VentureWell

John Younger, University City Science Center

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Moderator: Gavi Begtrup, Eccrine Systems (committee member)

Chang Hee Kim, GoDx

Peter Leonardi, OmniCyte

Donald McPherson, Enchroma

Chia Soo, University of California, Los Angeles, and Scarless Labs

Moderator: Joshua Graff Zivin, University of California, San Diego (committee member)

Donna Ginther, University of Kansas

Sabrina Howell, New York University

Moderator: Alicia Löffler, Northwestern University (committee member)

Michael O’Rand, Eppin Pharma

Stanley Kim, WinSanTor

David Mann, Vascular Biosciences

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Jodi Black, Matthew McMahon, and Stephanie Fertig, National Institutes of Health

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Randy Myer, University of North Carolina at Chapel Hill

Stephen Rapundalo, MichBio

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Jodi Black, Matthew McMahon, and Kathryn Fritz, National Institutes of Health

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Dimitri Krainc, Northwestern University Feinberg School of Medicine

John J. Puisis, COUR Pharmaceuticals Inc

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Maryann Feldman, University of North Carolina at Chapel Hill (co-chair)

Scott Stern, Massachusetts Institute of Technology (co-chair)

Matt McMahon, Stephanie Fertig, and Kathryn Fritz, National Institutes of Health